Sökning: WFRF:(Ek S.) > (2015-2019) > Update on the Globa...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 11025naa a2202749 4500 | |
001 | oai:prod.swepub.kib.ki.se:132348497 | |
003 | SwePub | |
008 | 240913s2015 | |||||||||||000 ||eng| | |
009 | oai:lup.lub.lu.se:f3ba1ef2-12c0-4333-a555-921179310c19 | |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1323484972 URI |
024 | 7 | a https://doi.org/10.1159/0004410852 DOI |
024 | 7 | a https://lup.lub.lu.se/record/83980852 URI |
040 | a (SwePub)kid (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Feigin, VL4 aut |
245 | 1 0 | a Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study |
264 | c 2015-10-28 | |
264 | 1 | b S. Karger AG,c 2015 |
520 | a <b><i>Background:</i></b> Global stroke epidemiology is changing rapidly. Although age-standardized rates of stroke mortality have decreased worldwide in the past 2 decades, the absolute numbers of people who have a stroke every year, and live with the consequences of stroke or die from their stroke, are increasing. Regular updates on the current level of stroke burden are important for advancing our knowledge on stroke epidemiology and facilitate organization and planning of evidence-based stroke care. <b><i>Objectives:</i></b> This study aims to estimate incidence, prevalence, mortality, disability-adjusted life years (DALYs) and years lived with disability (YLDs) and their trends for ischemic stroke (IS) and hemorrhagic stroke (HS) for 188 countries from 1990 to 2013. <b><i>Methodology:</i></b> Stroke incidence, prevalence, mortality, DALYs and YLDs were estimated using all available data on mortality and stroke incidence, prevalence and excess mortality. Statistical models and country-level covariate data were employed, and all rates were age-standardized to a global population. All estimates were produced with 95% uncertainty intervals (UIs). <b><i>Results:</i></b> In 2013, there were globally almost 25.7 million stroke survivors (71% with IS), 6.5 million deaths from stroke (51% died from IS), 113 million DALYs due to stroke (58% due to IS) and 10.3 million new strokes (67% IS). Over the 1990-2013 period, there was a significant increase in the absolute number of DALYs due to IS, and of deaths from IS and HS, survivors and incident events for both IS and HS. The preponderance of the burden of stroke continued to reside in developing countries, comprising 75.2% of deaths from stroke and 81.0% of stroke-related DALYs. Globally, the proportional contribution of stroke-related DALYs and deaths due to stroke compared to all diseases increased from 1990 (3.54% (95% UI 3.11-4.00) and 9.66% (95% UI 8.47-10.70), respectively) to 2013 (4.62% (95% UI 4.01-5.30) and 11.75% (95% UI 10.45-13.31), respectively), but there was a diverging trend in developed and developing countries with a significant increase in DALYs and deaths in developing countries, and no measurable change in the proportional contribution of DALYs and deaths from stroke in developed countries. <b><i>Conclusion:</i></b> Global stroke burden continues to increase globally. More efficient stroke prevention and management strategies are urgently needed to halt and eventually reverse the stroke pandemic, while universal access to organized stroke services should be a priority. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi0 (SwePub)303022 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Public Health, Global Health, Social Medicine and Epidemiology0 (SwePub)303022 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Neurologi0 (SwePub)302072 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Neurology0 (SwePub)302072 hsv//eng |
653 | a Hemorrhagic stroke | |
653 | a Ischemic stroke | |
653 | a Stroke | |
653 | a Global burden | |
653 | a GBD 2013 | |
700 | 1 | a Krishnamurthi, RV4 aut |
700 | 1 | a Parmar, P4 aut |
700 | 1 | a Norrving, Bou Lund University,Lunds universitet,Neurologi, Lund,Sektion IV,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Neurology, Lund,Section IV,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)neur-bno |
700 | 1 | a Mensah, GA4 aut |
700 | 1 | a Bennett, DA4 aut |
700 | 1 | a Barker-Collo, S4 aut |
700 | 1 | a Moran, AE4 aut |
700 | 1 | a Sacco, RL4 aut |
700 | 1 | a Truelsen, T4 aut |
700 | 1 | a Davis, S4 aut |
700 | 1 | a Pandian, JD4 aut |
700 | 1 | a Naghavi, M4 aut |
700 | 1 | a Forouzanfar, MH4 aut |
700 | 1 | a Nguyen, G4 aut |
700 | 1 | a Johnson, CO4 aut |
700 | 1 | a Vos, T4 aut |
700 | 1 | a Meretoja, A4 aut |
700 | 1 | a Murray, CJL4 aut |
700 | 1 | a Roth, GA4 aut |
700 | 1 | a Abd-Allah, F4 aut |
700 | 1 | a Abera, SF4 aut |
700 | 1 | a Akinyemi, RO4 aut |
700 | 1 | a Salman, RA4 aut |
700 | 1 | a Anderson, CS4 aut |
700 | 1 | a Bahit, MC4 aut |
700 | 1 | a Banerjee, A4 aut |
700 | 1 | a Basu, S4 aut |
700 | 1 | a Beauchamp, NJ4 aut |
700 | 1 | a Bornstein, NM4 aut |
700 | 1 | a Brainin, M4 aut |
700 | 1 | a Cabral, NL4 aut |
700 | 1 | a Campos-Nonato, I4 aut |
700 | 1 | a Caso, V4 aut |
700 | 1 | a Catala-Lopez, F4 aut |
700 | 1 | a Chowdhury, R4 aut |
700 | 1 | a Christensen, HK4 aut |
700 | 1 | a Connor, MD4 aut |
700 | 1 | a deVeber, G4 aut |
700 | 1 | a Dharmaratne, SD4 aut |
700 | 1 | a Dokova, K4 aut |
700 | 1 | a Donnan, G4 aut |
700 | 1 | a Endres, M4 aut |
700 | 1 | a Fernandes, JG4 aut |
700 | 1 | a Gankpe, F4 aut |
700 | 1 | a Geleijnse, JM4 aut |
700 | 1 | a Gillium, RF4 aut |
700 | 1 | a Giroud, M4 aut |
700 | 1 | a Hamadeh, RR4 aut |
700 | 1 | a Hankey, GJ4 aut |
700 | 1 | a Jeemon, P4 aut |
700 | 1 | a Jonas, JB4 aut |
700 | 1 | a Kazi, DS4 aut |
700 | 1 | a Kengne, AP4 aut |
700 | 1 | a Kim, D4 aut |
700 | 1 | a Kissela, BM4 aut |
700 | 1 | a Kokubo, Y4 aut |
700 | 1 | a Kosen, S4 aut |
700 | 1 | a Kravchenko, M4 aut |
700 | 1 | a Lavados, PM4 aut |
700 | 1 | a Liu, M4 aut |
700 | 1 | a Lotufo, PA4 aut |
700 | 1 | a Mackay, MT4 aut |
700 | 1 | a Malekzadeh, R4 aut |
700 | 1 | a Mehndiratta, MM4 aut |
700 | 1 | a Melaku, YA4 aut |
700 | 1 | a Misganaw, A4 aut |
700 | 1 | a Nand, D4 aut |
700 | 1 | a Piradov, M4 aut |
700 | 1 | a Pourmalek, F4 aut |
700 | 1 | a Rojas-Rueda, D4 aut |
700 | 1 | a Roy, Nu Karolinska Institutet4 aut |
700 | 1 | a Sahathevan, R4 aut |
700 | 1 | a Sampson, UKA4 aut |
700 | 1 | a Shamalov, N4 aut |
700 | 1 | a Sheth, KN4 aut |
700 | 1 | a Shinohara, Y4 aut |
700 | 1 | a Shiue, I4 aut |
700 | 1 | a Soljak, M4 aut |
700 | 1 | a Sposato, LA4 aut |
700 | 1 | a Stroumpoulis, K4 aut |
700 | 1 | a Tanne, D4 aut |
700 | 1 | a Thrift, AG4 aut |
700 | 1 | a Tirschwell, DL4 aut |
700 | 1 | a Varakin, Y4 aut |
700 | 1 | a Venketasubramanian, N4 aut |
700 | 1 | a Vlassov, VV4 aut |
700 | 1 | a Wang, WZ4 aut |
700 | 1 | a Westerman, R4 aut |
700 | 1 | a Wolfe, C4 aut |
700 | 1 | a Yu, CH4 aut |
700 | 1 | a Yunjin, K4 aut |
700 | 1 | a Meretoja, A4 aut |
700 | 1 | a Stavreski, B4 aut |
700 | 1 | a Pearse, E4 aut |
700 | 1 | a Davis, S4 aut |
700 | 1 | a Ademi, Z4 aut |
700 | 1 | a Guliyev, T4 aut |
700 | 1 | a Harewood, H4 aut |
700 | 1 | a Springer, K4 aut |
700 | 1 | a Leite, ID4 aut |
700 | 1 | a Lindsay, MP4 aut |
700 | 1 | a Riccio, PM4 aut |
700 | 1 | a Meretoja, A4 aut |
700 | 1 | a Stavreski, B4 aut |
700 | 1 | a Pearse, E4 aut |
700 | 1 | a Davis, S4 aut |
700 | 1 | a Ademi, Z4 aut |
700 | 1 | a Guliyev, T4 aut |
700 | 1 | a Harewood, H4 aut |
700 | 1 | a Springer, K4 aut |
700 | 1 | a Leite, ID4 aut |
700 | 1 | a Lindsay, MP4 aut |
700 | 1 | a Riccio, PM4 aut |
700 | 1 | a Li, B4 aut |
700 | 1 | a Jiang, GH4 aut |
700 | 1 | a Ma, JX4 aut |
700 | 1 | a Zhou, MG4 aut |
700 | 1 | a Zhu, SK4 aut |
700 | 1 | a Liang, XF4 aut |
700 | 1 | a Zhang, Y4 aut |
700 | 1 | a Alcala-Cerra, G4 aut |
700 | 1 | a Truelsen, T4 aut |
700 | 1 | a Temesgen, A4 aut |
700 | 1 | a Sahle, BW4 aut |
700 | 1 | a Prabhakaran, D4 aut |
700 | 1 | a Pandian, JD4 aut |
700 | 1 | a Gupta, R4 aut |
700 | 1 | a Rajagopalan, V4 aut |
700 | 1 | a Warouw, TS4 aut |
700 | 1 | a O'Donnell, MJ4 aut |
700 | 1 | a Bornstein, NM4 aut |
700 | 1 | a Ricci, S4 aut |
700 | 1 | a Asad, MM4 aut |
700 | 1 | a Bwire, VK4 aut |
700 | 1 | a Jee, SH4 aut |
700 | 1 | a Khang, YH4 aut |
700 | 1 | a Myint, CY4 aut |
700 | 1 | a Parmar, P4 aut |
700 | 1 | a Krishnamurthi, R4 aut |
700 | 1 | a Barker-Collo, S4 aut |
700 | 1 | a Feigin, V4 aut |
700 | 1 | a Norheim, O4 aut |
700 | 1 | a Khalifa, SE4 aut |
700 | 1 | a Shalamov, N4 aut |
700 | 1 | a Ngirabega, JDD4 aut |
700 | 1 | a Nyemazi, JP4 aut |
700 | 1 | a Muhimpundu, MA4 aut |
700 | 1 | a Saeedi, M4 aut |
700 | 1 | a Bedi, N4 aut |
700 | 1 | a Norrving, B4 aut |
700 | 1 | a Havmoeller, R4 aut |
700 | 1 | a Atwine, L4 aut |
700 | 1 | a Bennett, DA4 aut |
700 | 1 | a O'Callaghan, F4 aut |
700 | 1 | a Critchley, JA4 aut |
700 | 1 | a Ezzati, M4 aut |
700 | 1 | a Rothwell, PM4 aut |
700 | 1 | a Chowdhury, R4 aut |
700 | 1 | a Whiteley, W4 aut |
700 | 1 | a Chen, ZM4 aut |
700 | 1 | a Colomar, M4 aut |
700 | 1 | a Durrani, AM4 aut |
700 | 1 | a Dayama, A4 aut |
700 | 1 | a Moran, AE4 aut |
700 | 1 | a Amlie-Lefond, C4 aut |
700 | 1 | a Johnson, CO4 aut |
700 | 1 | a Huang, C4 aut |
700 | 1 | a Murray, CJ4 aut |
700 | 1 | a Sumeet, C4 aut |
700 | 1 | a Cundiff, DK4 aut |
700 | 1 | a Qato, D4 aut |
700 | 1 | a Kabagambe, EK4 aut |
700 | 1 | a Ding, E4 aut |
700 | 1 | a Bukhman, G4 aut |
700 | 1 | a Kwan, G4 aut |
700 | 1 | a Mensah, GA4 aut |
700 | 1 | a Thurston, G4 aut |
700 | 1 | a Nguyen, G4 aut |
700 | 1 | a Roth, GA4 aut |
700 | 1 | a Coresh, J4 aut |
700 | 1 | a Lefondulq, K4 aut |
700 | 1 | a Corriere, MA4 aut |
700 | 1 | a Forouzanfar, MH4 aut |
700 | 1 | a Naghavi, M4 aut |
700 | 1 | a Mainoo, N4 aut |
700 | 1 | a Sacco, RL4 aut |
700 | 1 | a Schwartz, SM4 aut |
700 | 1 | a Chugh, S4 aut |
700 | 1 | a Fung, T4 aut |
700 | 1 | a Vos, T4 aut |
700 | 1 | a Byers, TE4 aut |
700 | 1 | a Rocca, WA4 aut |
700 | 1 | a Lo, W4 aut |
700 | 1 | a Sposato, LA4 aut |
710 | 2 | a Neurologi, Lundb Sektion IV4 org |
773 | 0 | t Neuroepidemiologyd : S. Karger AGg 45:3, s. 161-176q 45:3<161-176x 1423-0208x 0251-5350 |
856 | 4 | u https://www.karger.com/Article/Pdf/441085 |
856 | 4 | u http://dx.doi.org/10.1159/000441085y FULLTEXT |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:132348497 |
856 | 4 8 | u https://doi.org/10.1159/000441085 |
856 | 4 8 | u https://lup.lub.lu.se/record/8398085 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy